Close filter

Ben Maddox

連絡先

+44 207 943 5817

つながる

Ben Maddox is active globally in Egon Zehnder’s Health Practice. He is an experienced strategic advisor with specialized expertise in pharma, biotech, and life sciences, with a passion for the benefits that science and innovation can bring to patients. Ben leads Executive and Board searches, as well as providing assessment and development support for senior leaders. He has a particular interest in C-suite and R&D leadership roles.

People are at the core of the health sector, both as patients and as leaders. I am energized by finding and developing the best leaders and enabling them to bring exciting scientific innovations to market.

Prior to joining Egon Zehnder, Ben was a Principal at IQVIA. At IQVIA he led the Cambridge, UK office and advised international pharma, biotech, and medical device clients on a wide range of business issues, including pricing and market access, clinical evidence generation, and brand strategy.

He holds a PhD in biochemistry and Masters in Natural Sciences from the University of Cambridge. Ben still lives in Cambridge with his wife and young daughters. Outside of work he enjoys spending time tinkering with technology.

得意分野

連絡をとる
Ben Maddoxにメッセージを送る
Browse all
Thought Leadership

関連するコンサルタント

Volha Pukhouskaya

Volha Pukhouskaya

Warsaw

Volha advises clients in Poland and CEE in executive searches, development of leaders and teams as well as of organizational transformation. 詳細

Pablo Sagnier

Pablo Sagnier

Barcelona, Lisbon, Madrid

Pablo Sagnier, based in Madrid and Barcelona, has deep expertise in search and in assessment and development of boards and executive teams. 詳細

Stephanie Levitt

Stephanie Levitt

Toronto

Stephanie Levitt is active in Egon Zehnder’s Health Practice, with a primary focus on the convergence of technology, health care and consumer… 詳細

Changing language
Close icon

You are switching to an alternate language version of the Egon Zehnder website. The page you are currently on does not have a translated version. If you continue, you will be taken to the alternate language home page.

Continue to the website

Back to top